Forkhead Transcription Factor FOXP3 Upregulates CD25 Expression through Cooperation with RelA/NF-κB

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Camperio, Cristina ^a   Caristi, Silvana ^a   Fanelli, Giorgia ^a   Soligo, Marzia ^a   De Porto, Paolal ^a   Piccolella, Enza ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RELA;

5' UNTRANSLATED REGION; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CD25 GENE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DIMERIZATION; FOXP3 GENE; GENE; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; UPREGULATION;

ANTIGENS, CD28; BASE SEQUENCE; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84868087600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048303     Document Type: Article

References (40)

1. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
2. Shevach EM, (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
3. Ziegler SF, (2006) FOXP3: of mice and men. Annu Rev Immunol 24: 209-226.
4. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, et al. (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20-21.
5. Gambineri E, Torgerson TR, Ochs HD, (2003) Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 15: 430-435.
6. Lopes JE, Torgerson TR, Schubert LA, Anover SD, Ocheltree EL, et al. (2006) Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol 177: 3133-3142.
7. Bandukwala HS, Wu Y, Feuerer M, Chen Y, Barboza B, et al. (2011) Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells. Immunity 34: 479-491.
8. Chen C, Rowell EA, Thomas RM, Hancock WW, Wells AD, (2006) Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J Biol Chem 281: 36828-36834.
9. Wu Y, Borde M, Heissmeyer V, Feuerer M, Lapan AD, et al. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126: 375-387.
10. Bettelli E, Dastrange M, Oukka M, (2005) Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci U S A 102: 5138-5143.
11. Ono M, Yaguchi H, Ohkura N, Kitabayashi I, Nagamura Y, et al. (2007) Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446: 685-689.
12. Li B, Samanta A, Song X, Iacono KT, Bembas K, et al. (2007) FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc Natl Acad Sci U S A 104: 4571-4576.
13. Samanta A, Li B, Song X, Bembas K, Zhang G, et al. (2008) TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc Natl Acad Sci U S A 105: 14023-14027.
14. van Loosdregt J, Vercoulen Y, Guichelaar T, Gent YY, Beekman JM, et al. (2010) Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115: 965-974.
15. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M, (1995) Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor alphachains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
16. Kim HP, Imbert J, Leonard WJ, (2006) Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev 17: 349-366.
17. Algarte M, Lecine P, Costello R, Plet A, Olive D, et al. (1995) In vivo regulation of interleukin-2 receptor alpha gene transcription by the coordinated binding of constitutive and inducible factors in human primary T cells. Embo J 14: 5060-5072.
18. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
19. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
20. Kane LP, Lin J, Weiss A, (2002) It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol 23: 413-420.
21. Scotta C, Soligo M, Camperio C, Piccolella E, (2008) FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes. J Immunol 181: 1025-1033.
22. Soligo M, Camperio C, Caristi S, Scotta C, Del Porto P, et al. (2011) CD28 costimulation regulates FOXP3 in a RelA/NF-κB-dependent mechanism. Eur J Immunol 41: 503-513.
23. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line trasformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
24. Schneider U, Schwenk H, Bornkamm G, (1977) Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 19: 621-626.
25. Tuosto L, Costanzo A, Guido F, Marinari B, Vossio S, et al. (2000) Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-κB activation. Eur J Immunol 30: 2445-2454.
26. Koh KP, Sundrud MS, Rao A, (2009) Domain requirements and sequence specificity of DNA binding for the forkhead transcription factor FOXP3. PLoS One 4: e8109.
27. Thomas RM, Gao L, Wells AD, (2005) Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J Immunol 174: 4639-4646.
28. Saccani S, Marazzi I, Beg AA, Natoli G, (2004) Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J Exp Med 200: 107-113.
29. Chae WJ, Henegariu O, Lee SK, Bothwell AL, (2006) The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells. Proc Natl Acad Sci U S A 103: 9631-9636.
30. Li B, Samanta A, Song X, Iacono KT, Brennan P, et al. (2007) FOXP3 is a homooligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int Immunol 19: 825-835.
31. Hu H, Djuretic I, Sundrud MS, Rao A, (2007) Transcriptional partners in regulatory T cells: Foxp3, Runx and NFAT. Trends Immunol 28: 329-332.
32. Lin BB, Cross SL, Halden NF, Roman DG, Toledano MB, et al. (1990) Delineation of an enhancerlike positive regulatory element in the interleukin-2 receptor alpha-chain gene. Mol Cell Biol 10: 850-853.
33. Kahn-Perles B, Lipcey C, Lecine P, Olive D, Imbert J, (1997) Temporal and subunit-specific modulations of the Rel/NF-kappaB transcription factors through CD28 costimulation. J Biol Chem 272: 21774-21783.
34. Schmidt-Supprian M, Tian J, Grant E P, Pasparakis M, Maehr R, Ovaa H, Ploegh HL, Coyle AJ, Rajewsky K, (2004) Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci U S A 101: 4566-4571.
35. Holmes D, Knudsen G, Mackey-Cushman S, Su L, (2007) FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells. J Biol Chem 282: 15973-15980.
36. Zhong H, May MJ, Jimi E, Ghosh S, (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636.
37. van Essen D, Engist B, Natoli G, Saccani S, (2009) Two modes of transcriptional activation at native promoters by NF-kappaB p65. PLoS Biol 7: e73.
38. Marson A, Kretschmer K, Frampton GM, Jacobsen ES, Polansky JK, et al. (2007) Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445: 931-935.
39. Zheng Y, Rudensky AY, (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8: 457-462.
40. Sadlon TJ, Wilkinson BG, Pederson S, Brown CY, Bresatz S, et al. (2010) Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J Immunol 185: 1071-1081.